Antimicrobial Peptides, Skin Infections, and Atopic Dermatitis
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, several AMPs can modulate immune and inflammatory responses, inducing phagocytosis, promotion of immune cell recruitment, regulation of angiogenesis, and stimulation of prostaglandin release (13, 19, 20, 25–29)”
From On the Role of NMR Spectroscopy for Characterization of Antimicrobial Peptides (2013) · cites this paper as [19]
In the citing paper
“Since this pioneering research, more than 1800 AMPs have been identified and isolated from several organisms, and structural analogues have been synthesized and tested for clinical purposes (16–22).”
From On the Role of NMR Spectroscopy for Characterization of Antimicrobial Peptides (2013) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924
Self-citationDefensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Self-citationInnate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Self-citationAgerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jörnvall, H., Wigzell, H., & Gudmundsson, G. H. (2000) · Blood · doi:10.1182/blood.v96.9.3086 · Cited by 758
Dermcidin: A novel human antibiotic peptide secreted by sweat glands
Schittek, B., Hipfel, R., Sauer, B., Bauer, J., Kalbacher, H., Stevanovic, S., Schirle, M., Schroeder, K., Blin, N., Meier, F., et al. (2001) · Nature Immunology · doi:10.1038/ni732 · Cited by 730
Schröder, N. W. J., Morath, S., Alexander, C., Hamann, L., Hartung, T., Zähringer, U., Göbel, U. B., Weber, J. R., & Schumann, R. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212829200 · Cited by 641
Toll-like receptors — taking an evolutionary approach
Leulier, F., & Lemaitre, B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2303 · Cited by 581
Postlethwaite, A. E., Holness, M. A., Katai, H., & Raghow, R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116015 · Cited by 504
Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies
Braff, M. H., Nardo, A. D., & Gallo, R. L. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23443.x · Cited by 213
Self-citationMechanism of HBD-3 deficiency in atopic dermatitis
Howell, M. D., Boguniewicz, M., Pastore, S., Novak, N., Bieber, T., Girolomoni, G., & Leung, D. Y. M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.08.008 · Cited by 208
Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic Dermatitis
Howell, M. D., Novak, N., Bieber, T., Pastore, S., Girolomoni, G., Boguniewicz, M., Streib, J., Wong, C., Gallo, R. L., & Leung, D. Y. M. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23776.x · Cited by 193
Self-citationThe relationship of transepidermal water loss to skin temperature in psoriasis and eczema
Grice, K., Sattar, H., Baker, H., & Sharratt, M. (1975) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12512258 · Cited by 65
Research works printed but not linked: 106
- Irvine, 2006, Breaking the (un)sound barrier: Filaggrin is a major gene for atopic dermatitis, J Invest Dermatol, 126, 1200, 10.1038/sj.jid.5700365 · DOI · Paper page
- Nomura, 2007, Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis, J Allergy Clin Immunol, 119, 434, 10.1016/j.jaci.2006.12.646 · DOI · Paper page
- Nomura, 2008, Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan, J Invest Dermatol, 128, 1436, 10.1038/sj.jid.5701205 · DOI
- Sandilands, 2007, Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema, Nat Genet, 39, 650, 10.1038/ng2020 · DOI · Paper page
- Irvine, 2007, Fleshing out filaggrin phenotypes, J Invest Dermatol, 127, 504, 10.1038/sj.jid.5700695 · DOI
- Marenholz, 2006, Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march, J Allergy Clin Immunol, 118, 866, 10.1016/j.jaci.2006.07.026 · DOI · Paper page
- Weidinger, 2006, Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations, J Allergy Clin Immunol, 118, 214, 10.1016/j.jaci.2006.05.004 · DOI · Paper page
- Barker, 2007, Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood, J Invest Dermatol, 127, 564, 10.1038/sj.jid.5700587 · DOI · Paper page
- Weidinger, 2007, Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis, J Invest Dermatol, 127, 724, 10.1038/sj.jid.5700630 · DOI · Paper page
- Palmer, 2007, Filaggrin null mutations are associated with increased asthma severity in children and young adults, J Allergy Clin Immunol, 120, 64, 10.1016/j.jaci.2007.04.001 · DOI · Paper page
- Gallo, 2003, Endogenous production of antimicrobial peptides in innate immunity and human disease, Curr Allergy Asthma Rep, 3, 402, 10.1007/s11882-003-0074-x · DOI
- Nizet, 2003, Cathelicidins and innate defense against invasive bacterial infection, Scand J Infect Dis, 35, 670, 10.1080/00365540310015629 · DOI
- Kang, 2006, Toll-like receptors: applications to dermatologic disease, J Am Acad Dermatol, 54, 951, 10.1016/j.jaad.2005.05.004 · DOI
- Janeway, 2002, Innate immune recognition, Annu Rev Immunol, 20, 197, 10.1146/annurev.immunol.20.083001.084359 · DOI · Paper page
- Medzhitov, 1997, Innate immunity: Impact on the adaptive immune response, Curr Opin Immunol, 9, 4, 10.1016/S0952-7915(97)80152-5 · DOI · Paper page
- Mempel, 2003, Toll-like receptor expression in human keratinocytes: Nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent, J Invest Dermatol, 121, 1389, 10.1111/j.1523-1747.2003.12630.x · DOI · Paper page
- Kollisch, 2005, Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes, Immunology, 114, 531, 10.1111/j.1365-2567.2005.02122.x · DOI · Paper page
- Gay, 1991, Drosophila Toll and IL-1 receptor, Nature, 351, 355, 10.1038/351355b0 · DOI · Paper page
- Hawlisch, 2006, Complement and Toll-like receptors: Key regulators of adaptive immune responses, Mol Immunol, 43, 13, 10.1016/j.molimm.2005.06.028 · DOI · Paper page
- Beutler, 2004, Inferences, questions and possibilities in Toll-like receptor signalling, Nature, 430, 257, 10.1038/nature02761 · DOI · Paper page
- Ahmad-Nejad, 2004, The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype, J Allergy Clin Immunol, 113, 565, 10.1016/j.jaci.2003.12.583 · DOI · Paper page
- Weidinger, 2005, Association of NOD1 polymorphisms with atopic eczema and related phenotypes, J Allergy Clin Immunol, 116, 177, 10.1016/j.jaci.2005.02.034 · DOI · Paper page
- Dziarski, 2003, Recognition of bacterial peptidoglycan by the innate immune system, Cell Mol Life Sci, 60, 1793, 10.1007/s00018-003-3019-6 · DOI · Paper page
- Zdolsek, 2004, Reduced levels of soluble CD14 in atopic children, Clin Exp Allergy, 34, 532, 10.1111/j.1365-2222.2004.1921.x · DOI
- Rothenbacher, 2005, Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort study, Clin Exp Allergy, 35, 1014, 10.1111/j.1365-2222.2005.02298.x · DOI
- Jones, 2002, Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both, J Allergy Clin Immunol, 109, 858, 10.1067/mai.2002.123535 · DOI
- Steiner, 1981, Sequence and specificity of two antibacterial proteins involved in insect immunity, Nature, 292, 246, 10.1038/292246a0 · DOI · Paper page
- Ganz, 1985, Defensins, J Clin Invest, 76, 1427, 10.1172/JCI112120 · DOI · Paper page
- Mallow, 1996, Human enteric defensins, J Biol Chem, 271, 4038, 10.1074/jbc.271.8.4038 · DOI · Paper page
- Cole, 2002, Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1, Proc Natl Acad Sci U S A, 99, 1813, 10.1073/pnas.052706399 · DOI · Paper page
- Fulton, 1997, Expression of natural peptide antibiotics in human skin, Lancet, 350, 1750, 10.1016/S0140-6736(05)63574-X · DOI · Paper page
- Ali, 2001, Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin, J Invest Dermatol, 117, 106, 10.1046/j.0022-202x.2001.01401.x · DOI · Paper page
- Zhao, 1996, Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells, FEBS Lett, 396, 319, 10.1016/0014-5793(96)01123-4 · DOI · Paper page
- Liu, 2002, Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation, J Invest Dermatol, 118, 275, 10.1046/j.0022-202x.2001.01651.x · DOI · Paper page
- Harder, 2001, Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic, J Biol Chem, 276, 5707, 10.1074/jbc.M008557200 · DOI · Paper page
- Harder, 2004, Differential gene induction of human beta-defensins (hBD-1, −2, −3, and −4) in keratinocytes is inhibited by retinoic acid, J Invest Dermatol, 123, 522, 10.1111/j.0022-202X.2004.23234.x · DOI · Paper page
- Harder, 1997, A peptide antibiotic from human skin, Nature, 387, 861, 10.1038/43088 · DOI · Paper page
- Ericksen, 2005, Antibacterial activity and specificity of the six human {alpha}-defensins, Antimicrob Agents Chemother, 49, 269, 10.1128/AAC.49.1.269-275.2005 · DOI · Paper page
- Wilde, 1989, Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family, J Biol Chem, 264, 11200, 10.1016/S0021-9258(18)60449-1 · DOI · Paper page
- Hoover, 2003, Antimicrobial characterization of human beta-defensin 3 derivatives, Antimicrob Agents Chemother, 47, 2804, 10.1128/AAC.47.9.2804-2809.2003 · DOI · Paper page
- Bastian, 2001, Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro, Regul Pept, 101, 157, 10.1016/S0167-0115(01)00282-8 · DOI · Paper page
- Buck, 2006, Human alpha-defensins block papillomavirus infection, Proc Natl Acad Sci U S A, 103, 1516, 10.1073/pnas.0508033103 · DOI · Paper page
- Sun, 2005, Human beta-defensins suppress human immunodeficiency virus infection: Potential role in mucosal protection, J Virol, 79, 14318, 10.1128/JVI.79.22.14318-14329.2005 · DOI · Paper page
- Chang, 2005, Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity, J Clin Invest, 115, 765, 10.1172/JCI21948 · doi:10.1172/jci21948 · Paper page
- Hazrati, 2006, Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection, J Immunol, 177, 8658, 10.4049/jimmunol.177.12.8658 · DOI · Paper page
- Chaly, 2000, Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells, Eur Cytokine Netw, 11, 257
- van Wetering, 2002, Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone, Inflamm Res, 51, 8, 10.1007/PL00000282 · DOI
- Van Wetering, 1997, Effect of defensins on interleukin-8 synthesis in airway epithelial cells, Am J Physiol, 272, L888
- Niyonsaba, 2005, The human beta-defensins (−1, −2, −3, −4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes, J Immunol, 175, 1776, 10.4049/jimmunol.175.3.1776 · DOI · Paper page
- Zanetti, 1995, Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain, FEBS Lett, 374, 1, 10.1016/0014-5793(95)01050-O · DOI · Paper page
- Ritonja, 1989, Primary structure of a new cysteine proteinase inhibitor from pig leucocytes, FEBS Lett, 255, 211, 10.1016/0014-5793(89)81093-2 · DOI · Paper page
- Zelezetsky, 2006, Evolution of the primate cathelicidin, J Biol Chem, 281, 19861, 10.1074/jbc.M511108200 · DOI
- Murakami, 2004, Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense, J Immunol, 172, 3070, 10.4049/jimmunol.172.5.3070 · DOI · Paper page
- Yamasaki, 2006, Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin, FASEB J, 20, 2068, 10.1096/fj.06-6075com · DOI · Paper page
- Frohm, 1997, The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders, J Biol Chem, 272, 15258, 10.1074/jbc.272.24.15258 · DOI · Paper page
- Schauber, 2007, Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism, J Clin Invest, 117, 803, 10.1172/JCI30142 · DOI · Paper page
- Schauber, 2006, Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli, Immunology, 118, 509, 10.1111/j.1365-2567.2006.02399.x · DOI · Paper page
- Peyssonaux, 2004, An unexpected role for hypoxic response: Oxygenation and inflammation, Cell Cycle, 3, 168, 10.4161/cc.3.2.687 · DOI
- Gallo, 1997, Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse, J Biol Chem, 272, 13088, 10.1074/jbc.272.20.13088 · DOI · Paper page
- Di Nardo, 2003, Cutting edge: Mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide, J Immunol, 170, 2274, 10.4049/jimmunol.170.5.2274 · DOI · Paper page
- Borregaard, 1997, Granules of the human neutrophilic polymorphonuclear leukocyte, Blood, 89, 3503, 10.1182/blood.V89.10.3503 · DOI · Paper page
- Frohm, 1996, Biochemical and antibacterial analysis of human wound and blister fluid, Eur J Biochem, 237, 86, 10.1111/j.1432-1033.1996.0086n.x · DOI · Paper page
- Agerberth, 1999, Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients, Am J Respir Crit Care Med, 160, 283, 10.1164/ajrccm.160.1.9807041 · DOI · Paper page
- Murakami, 2002, Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin, J Invest Dermatol, 119, 1090, 10.1046/j.1523-1747.2002.19507.x · DOI · Paper page
- Murakami, 2002, Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva, J Dent Res, 81, 845, 10.1177/154405910208101210 · DOI · Paper page
- Marchini, 2002, The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa, Br J Dermatol, 147, 1127, 10.1046/j.1365-2133.2002.05014.x · DOI · Paper page
- Henzler Wildman, 2003, Mechanism of lipid bilayer disruption by the human antimicrobial peptide LL-37, Biochemistry, 42, 6545, 10.1021/bi0273563 · DOI · Paper page
- Gutsmann, 2001, Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids, Biophys J, 80, 2935, 10.1016/S0006-3495(01)76259-5 · DOI
- Rosenberger, 2004, Interplay between antibacterial effectors: A macrophage antimicrobial peptide impairs intracellular Salmonella replication, Proc Natl Acad Sci U S A, 101, 2422, 10.1073/pnas.0304455101 · DOI · Paper page
- Iimura, 2005, Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens, J Immunol, 174, 4901, 10.4049/jimmunol.174.8.4901 · DOI · Paper page
- Howell, 2004, Selective killing of vaccinia virus by LL-37: Implications for eczema vaccinatum, J Immunol, 172, 1763, 10.4049/jimmunol.172.3.1763 · DOI · Paper page
- Lopez-Garcia, 2005, Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection, J Invest Dermatol, 125, 108, 10.1111/j.0022-202X.2005.23713.x · DOI · Paper page
- Dorschner, 2004, Innate immune defense of the nail unit by antimicrobial peptides, J Am Acad Dermatol, 50, 343, 10.1016/j.jaad.2003.09.010 · DOI
- Braff, 2005, Structure-function relationships among human cathelicidin peptides: Dissociation of antimicrobial properties from host immunostimulatory activities, J Immunol, 174, 4271, 10.4049/jimmunol.174.7.4271 · DOI · Paper page
- Tjabringa, 2003, The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor, J Immunol, 171, 6690, 10.4049/jimmunol.171.12.6690 · DOI · Paper page
- Niyonsaba, 2007, Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines, J Invest Dermatol, 127, 594, 10.1038/sj.jid.5700599 · DOI · Paper page
- De, 2000, LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells, J Exp Med, 192, 1069, 10.1084/jem.192.7.1069 · DOI · Paper page
- Rieg, 2004, Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions, Br J Dermatol, 151, 534, 10.1111/j.1365-2133.2004.06081.x · DOI · Paper page
- Baechle, 2006, Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L, J Biol Chem, 281, 5406, 10.1074/jbc.M504670200 · DOI · Paper page
- Lai, 2005, Functional and structural characterization of recombinant dermcidin-1L, a human antimicrobial peptide, Biochem Biophys Res Commun, 328, 243, 10.1016/j.bbrc.2004.12.143 · DOI
- Lin, 2007, Role of bacterial pathogens in atopic dermatitis, Clin Rev Allergy Immunol, 33, 167, 10.1007/s12016-007-0044-5 · DOI
- Williams, 1990, Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis, Br J Dermatol, 123, 493, 10.1111/j.1365-2133.1990.tb01455.x · DOI · Paper page
- Leung, 2003, Infection in atopic dermatitis, Curr Opin Pediatr, 15, 399, 10.1097/00008480-200308000-00008 · DOI · Paper page
- Nomura, 2003, Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes, J Immunol, 171, 3262, 10.4049/jimmunol.171.6.3262 · DOI · Paper page
- Homey, 2006, Cytokines and chemokines orchestrate atopic skin inflammation, J Allergy Clin Immunol, 118, 178, 10.1016/j.jaci.2006.03.047 · DOI · Paper page
- Jeong, 2003, Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs, extrinsic atopic dermatitis patients using semiquantitative RT-PCR: Clin Exp Allergy, 33, 1717
- Kaburagi, 2001, Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha MIP-1beta, and eotaxin) in patients with atopic dermatitis, Arch Dermatol Res, 293, 350, 10.1007/s004030100230 · DOI
- Campbell, 2000, Chemokines in tissue-specific and microenvironment-specific lymphocyte homing, Curr Opin Immunol, 12, 336, 10.1016/S0952-7915(00)00096-0 · DOI · Paper page
- Howell, 2006, Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus, Immunity, 24, 341, 10.1016/j.immuni.2006.02.006 · DOI · Paper page
- Nishijima, 1995, Staphylococcus aureus on hand surface and nasal carriage in patients with atopic dermatitis, J Am Acad Dermatol, 32, 677, 10.1016/0190-9622(95)90376-3 · doi:10.1016/0190-9622(95)90376-3
- Grassegger, 2004, Significance of the cytokine interferon gamma in clinical dermatology, Clin Exp Dermatol, 29, 584, 10.1111/j.1365-2230.2004.01652.x · DOI
- Machura, 2008, Staphylococcus aureus skin colonization in atopic dermatitis children is associated with decreased IFN-gamma production by peripheral blood CD4+ and CD8+ T cells, Pediatr Allergy Immunol, 19, 37, 10.1111/j.1399-3038.2007.00586.x · DOI
- Rieg, 2005, Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo, J Immunol, 174, 8003, 10.4049/jimmunol.174.12.8003 · DOI · Paper page
- Cho, 2001, Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model, J Invest Dermatol, 116, 658, 10.1046/j.0022-202x.2001.01331.x · DOI · Paper page
- Cho, 2001, Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin, J Allergy Clin Immunol, 108, 269, 10.1067/mai.2001.117455 · DOI · Paper page
- Wann, 2000, The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen, J Biol Chem, 275, 13863, 10.1074/jbc.275.18.13863 · DOI · Paper page
- Plaut, 2003, Risks of smallpox vaccination: 200 years after Jenner, J Allergy Clin Immunol, 112, 683, 10.1016/j.jaci.2003.07.002 · DOI
- Bicknell, 2002, The case for voluntary smallpox vaccination, N Engl J Med, 346, 1323, 10.1056/NEJM200204253461713 · doi:10.1056/nejm200204253461713
- Wharton, 2003, Recommendations for using smallpox vaccine in a pre-event vaccination program, MMWR Recomm Rep, 52, 1
- Marris, 2007, Dramatic rescue relieves rare case of smallpox infection, Nat Med, 13, 517, 10.1038/nm0507-517 · doi:10.1038/nm0507-517
- Wollenberg, 2003, Viral infections in atopic dermatitis: pathogenic aspects and clinical management, J Allergy Clin Immunol, 112, 667, 10.1016/j.jaci.2003.07.001 · DOI · Paper page
- Peng, 2007, Risk factors of atopic dermatitis patients for eczema herpeticum, J Invest Dermatol, 127, 1261, 10.1038/sj.jid.5700657 · DOI
- Howell, 2006, Cathelicidin deficiency predisposes to eczema herpeticum, J Allergy Clin Immunol, 117, 836, 10.1016/j.jaci.2005.12.1345 · DOI · Paper page
- Uchida, 2001, Increase of dendritic cells of type 2 (DC2) by altered response to IL-4 in atopic patients, J Allergy Clin Immunol, 108, 1005, 10.1067/mai.2001.119741 · DOI
- Wollenberg, 2002, Plasmacytoid dendritic cells: A new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases, J Invest Dermatol, 119, 1096, 10.1046/j.1523-1747.2002.19515.x · DOI · Paper page
- Rissoan, 1999, Reciprocal control of T helper cell and dendritic cell differentiation, Science, 283, 1183, 10.1126/science.283.5405.1183 · DOI · Paper page
Cited by
The Roles of Antimicrobial Peptides in Innate Host Defense
Diamond, G., Beckloff, N., Weinberg, A., & Kisich, K. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682325 · Cited by 642
Structure and function of the human skin microbiome
Schommer, N. N., & Gallo, R. L. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.10.001 · Cited by 532
Self-citationFunctions of the skin microbiota in health and disease
Sanford, J. A., & Gallo, R. L. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.09.005 · Cited by 479
Self-citationAnionic Antimicrobial Peptides from Eukaryotic Organisms
Harris, F., Dennison, S., & Phoenix, D. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789630589 · Cited by 332
Antimicrobial Peptides: Versatile Biological Properties
Pushpanathan, M., Gunasekaran, P., & Rajendhran, J. (2013) · International Journal of Peptides · doi:10.1155/2013/675391 · Cited by 292
Metadata
- Authors
- Hata, T. R., & Gallo, R. L.
- Venue
- Seminars in Cutaneous Medicine and Surgery
- Published
- 2008-06
- Volume
- 27
- Issue
- 2
- Pages
- 144-150
- ISSN
- 1085-5629
- Cited by
- 102
- References
- 13
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.